Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Corinne Johnson's Stock Ratings
Goldman Sachs Analyst
Corinne Johnson is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Overall Average Return
-14.2%
Smart Score
Overall Average Return Percentile
15th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/24/2024 | RNA | Buy Now | Avidity Biosciences | $29.52 | 99.86% | Corinne Johnson23% | → $59 | Initiates | → Buy | Get Alert |
| 09/10/2024 | AVBP | Buy Now | ArriVent BioPharma | $25.22 | 50.67% | Corinne Johnson23% | $28 → $38 | Maintains | Buy | Get Alert |
| 05/14/2024 | CGON | Buy Now | CG Oncology | $25.55 | 95.69% | Corinne Johnson23% | $43 → $50 | Upgrade | Neutral → Buy | Get Alert |
| 05/13/2024 | CGON | Buy Now | CG Oncology | $25.55 | 95.69% | Corinne Johnson23% | → $50 | Upgrade | Neutral → Buy | Get Alert |
| 03/13/2024 | IMVT | Buy Now | Immunovant | $15.80 | 216.46% | Corinne Johnson23% | → $50 | Initiates | → Buy | Get Alert |
| 02/20/2024 | AVBP | Buy Now | ArriVent BioPharma | $25.22 | 7.06% | Corinne Johnson23% | → $27 | Initiates | → Buy | Get Alert |
| 02/20/2024 | CGON | Buy Now | CG Oncology | $25.55 | 64.38% | Corinne Johnson23% | → $42 | Initiates | → Neutral | Get Alert |
